8-K: OneMedNet Regains Nasdaq Listing Compliance

OneMedNet Corporation announced it has regained compliance with Nasdaq's minimum market value requirement, resolving a previous listing deficiency.

Summary

• OneMedNet Corporation received a notice on September 11, 2025, from The Nasdaq Stock Market Staff confirming it had regained compliance with Nasdaq Listing Rule 5550(b)(2).
• The company had previously been notified on March 12, 2025, that it failed to maintain a minimum market value of listed securities of $35,000,000.
• A grace period was provided until September 2025 to regain compliance.
• For 10 consecutive business days, from August 27, 2025, to September 10, 2025, the company's market value of listed securities was $35,000,000 or greater.
• As a result, the matter regarding the minimum market value requirement is now closed.

Sentiment

Score: 8

Explanation: The sentiment is highly positive as the company successfully resolved a critical regulatory compliance issue that could have led to delisting, thereby removing a significant overhang and risk for investors.

Positives

• Regained compliance with Nasdaq Listing Rule 5550(b)(2), removing the threat of delisting.
• The company successfully maintained a market value of listed securities of $35,000,000 or greater for the required 10 consecutive business days.

Negatives

• The company previously failed to maintain the minimum market value of listed securities, leading to a non-compliance notice.

Risks

• Potential delisting from The Nasdaq Capital Market due to not meeting the minimum market value requirement (now resolved).

Future Outlook

The company has successfully resolved its Nasdaq listing deficiency, ensuring its continued presence on The Nasdaq Capital Market. No other forward-looking statements were provided.

Management Comments

• Aaron Green, Chief Executive Officer, duly authorized the signing of this report on behalf of OneMedNet Corporation.

Industry Context

Maintaining a listing on a major exchange like Nasdaq is crucial for public companies, as it provides liquidity, visibility, and access to capital markets. Non-compliance with listing standards can lead to delisting, which often negatively impacts investor confidence and stock price. OneMedNet's regaining of compliance aligns with standard practices for companies addressing regulatory requirements to maintain their market presence.

Comparison to Industry Standards

• Maintaining a minimum market capitalization or share price is a common listing requirement across major stock exchanges globally, including the NYSE, LSE, and TSX. Companies like OneMedNet that fall below these thresholds are typically given a grace period to regain compliance, similar to the process followed by Nasdaq.
• The $35,000,000 market value requirement for Nasdaq Capital Market is specific to that exchange and tier, with other exchanges or tiers having different thresholds (e.g., Nasdaq Global Market has higher requirements, while some smaller exchanges might have lower or different criteria).

Stakeholder Impact

• Shareholders: Positive impact as the risk of delisting is removed, preserving the liquidity and marketability of their shares on Nasdaq.
• Investors: Increased confidence due to the resolution of a significant regulatory concern.

Next Steps

• The company must continue to monitor and maintain its market value of listed securities to ensure ongoing compliance with Nasdaq's listing rules.

Key Dates

Recommendation

The resolution of the Nasdaq compliance issue removes a significant downside risk (delisting) and is a positive development. However, this filing does not provide information on operational performance, financial results, or strategic growth initiatives that would warrant a 'buy' recommendation. It primarily addresses a regulatory hurdle. Therefore, a 'hold' recommendation is appropriate, acknowledging the risk mitigation while awaiting further fundamental business updates.

Keywords

Nasdaq compliance, market value, listing standards, ONMD, regulatory compliance, SEC filing, stock market, delisting risk